5 Best Psychedelic Stocks to Buy According to Analysts

Page 1 of 5

In this article, we will be taking a look at the 5 Best Psychedelic Stocks to Buy According to Analysts. If you wish to see the full list, visit 7 Best Psychedelic Stocks to Buy According to Analysts.

5 Best Psychedelic Stocks to Buy According to Analysts

wavebreakmedia/Shutterstock.com

5. Silo Pharma, Inc. (NASDAQ:SILO)

Price Target Upside: 76.68%

Silo Pharma, Inc. (NASDAQ:SILO) is one of the best psychedelic stocks on our list.

SILO reported on July 7 that its wholly owned subsidiary, QwikAgents, joined the NVIDIA Developer Program to support the advancement of its artificial intelligence agent integration platform. The program provides QwikAgents with access to NVIDIA’s AI software ecosystem, development tools, technical resources, and optimization support aimed at improving next-generation AI applications. QwikAgents’ platform is designed to automate complex business processes through autonomous AI agents capable of reasoning, executing tasks, and connecting with enterprise systems. The company expects these resources to help accelerate platform development as it expands solutions for organizations seeking scalable AI-driven operations.

Separately, on June 29, Silo Pharma, Inc. (NASDAQ:SILO) announced that it had partnered with Resyca to conduct a robustness evaluation of the microchip-based nasal spray technology being developed for SPC-15, its lead intranasal treatment candidate for post-traumatic stress disorder. The study will assess device reliability during expected use and examine formulation stability over 30 days. SILO believes the nose-to-brain delivery approach may improve drug concentration in the brain while limiting systemic exposure, potentially supporting faster therapeutic effects and enhanced safety. The company is also using regulatory discussions with the FDA to advance development of SPC-15 through the streamlined 505 pathway.

Silo Pharma, Inc. (NASDAQ:SILO) is a developmental-stage biopharmaceutical company combining psychedelic research with traditional therapeutics to develop treatments for conditions such as PTSD, Alzheimer’s disease, multiple sclerosis, and chronic pain.

Page 1 of 5
1281292 - 11759070 - 1